欢迎访问ProbeChem中文网站,英文网站请访问www.probechem.com

首页-抗体药物偶连体和PROTACs-PROTAC-NRX-0492
NRX-0492

Chemical Structure : NRX-0492

CAS No.: 2416130-57-7

NRX-0492 (NRX0492)

货号: PC-24021Not For Human Use, Lab Use Only.

NRX-0492 is a potent, selective cereblon (CRBN)-basesd PROTAC degrader of wild-type and C481 mutant BTK with DC50 of 0.1 nM and 0.2 nM, and DC90 of 0.3 nM and 0.5 nM in TMD8 cells expressing WT or C481S mutant BTK respectively.

规格 价格 库存 数量
2 mg ¥2480 In stock
5 mg ¥3980 In stock
10 mg ¥5880 In stock
25 mg Get quote
100 mg Get quote

大包装,大折扣!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

纯度 & COA & 质检文件 纯度: >98% (HPLC) Select Batch:

生物&药学活性

NRX-0492 is a potent, selective cereblon (CRBN)-basesd PROTAC degrader of wild-type and C481 mutant BTK with DC50 of 0.1 nM and 0.2 nM, and DC90 of 0.3 nM and 0.5 nM in TMD8 cells expressing WT or C481S mutant BTK respectively.
NRX-0492 has IC50 of 1.2 nM and 9 nM for BTK WT protein and CRBN respectively.
NRX-0492 shows binding affinities to BTK proteins harboring 2 acquired inhibitor-resistance mutations (C481S or T474I) with IC50 of 2.7 nM and 1.2 nM in FRET competition assays.
NRX-0492 selectively degrades BTK via a cereblon (CRBN)- and proteasome-dependent mechanism.
NRX-0492 decreases in IKZF1 and IKZF3 levels in TMD8 and MOLT4 cells.
NRX-0492 induces sustained E3 ligase-dependent BTK degradation in primary CLL cells.
NRX-0492 inhibits BCR and NF-κB signaling, exhibits strong downregulation of BCR, NF-κB, and MYC regulated genes consistent with effective inhibition of BTK-dependent signaling in CLL cells from patients.
NRX-0492 inhibits treatment-naïve CLL cell proliferation and activation in in the CLL PDX model of treatment- naïve CLL, degrades C481S mutant BTK in CLL cells from patients progressing on IBR.

物理化学性质&存储条件

分子量 817.95
分子式 C43H51N11O6
外观性状 Solid
CAS No.
储存条件
固体粉末
-20°C 12 个月; 4°C 6 个月
配置液
-80°C 6 个月; -20°C 6 个月
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

3-((4-(1-(((3S)-1-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)pyrrolidin-3-yl)methyl)piperidin-4-yl)phenyl)amino)-5-((R)-3-(3-methyl-2-oxoimidazolidin-1-yl)piperidin-1-yl)pyrazine-2-carboxamide

参考文献

1. Zhang D, et al. Blood. 2023 Mar 30;141(13):1584-1596.

备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

联系我们 sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

询单

  • *产品名称:
  • *姓名:
  • *邮箱:
  • *公司名称:
  • *询单数量:
  • *国籍:
  • 询单信息: